Furthermore, drugs such as the PTEN inhibitor VO-OHpic (VO), Mdm2-p53 interaction inhibitor nutlin 3, RG7112, and UBX0101 can induce cancer cell senescence via the p53-p21 signaling pathway [145]. Here, CDKN1A is linked to cancer.